In the UK, the diagnostic approach typically includes faecal calprotectin testing (as per NICE DG11) to distinguish between inflammatory and functional bowel disorders in primary care, alongside blood tests and stool examinations
This characteristic may improve renal function by increasing renal blood flow, urine flow rate, preventing elevated plasma creatinine, reducing tubular necrosis, increasing renal interstitial fluid and glomerular filtration rate, and cytoprotective and anti-inflammatory effects [12,13], and may improve glomerular hyperosmosis in patients with T2DM in some cases [14]
Phase 2 Type 2 Diabetes Trial A separate Phase 2 trial evaluated retatrutide in adults with type 2 diabetes
Medical Assessments: Regularly monitoring and treating any underlying medical conditions that may affect your weight
The risk of gastrointestinal side effects may increase in pregnant females
After the initial period, the dose may be increased to 0.5 mg up to a maximum of 2 mg once a week if additional glycemic control is needed